Twist Bioscience Corporation (NASDAQ ... today announced financial results and business highlights for the first quarter fiscal 2025 ended December 31, 2024. The company plans to hold a conference ...

Research analysts at William Blair issued their Q2 2026 earnings per share (EPS) estimates for Twist Bioscience in a report issued on Tuesday, February 4th. William Blair analyst M. Larew anticipates ...

Thank you for standing by. Welcome to Twist Bioscience's 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers ...

Twist Bioscience, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $88.71 million for the quarter ended December 2024, surpassing the Zacks Consensus ...

February 03, 2025--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ ... financial results and business highlights for the first quarter fiscal 2025 ended December 31, 2024.

Good day. Thank you for standing by. Welcome to Twist Bioscience's 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the ...